Published
HPLC separates peptide sample components; mass spectrometry adds mass information. Read each result’s method, reporting basis and limitations before interpreting purity, identity or quantity.
This guide helps readers interpret laboratory documentation. It is not a substitute for the laboratory’s method, specifications or complete findings.
What is the difference between HPLC and mass spectrometry?
| Method or result | Useful reading question | Separate check |
|---|---|---|
| HPLC with UV detection | Which peaks were separated and integrated under the stated method? | How was the target identified and the percentage defined? |
| Mass spectrometry | How do the observed masses compare with the expected material? | What identification criteria and method limits apply? |
| LC-MS | How are the chromatographic separation and mass information interpreted together? | Does the report include a separately supported quantity result? |
Bachem’s quality-control guide describes analytical HPLC with UV detection for peptide purity and mass spectrometry for molecular-weight information. It also identifies other tests for properties such as water, residual solvents and counterions. One measurement does not automatically supply the others. Bachem: quality control of peptides.
Does a single large HPLC peak mean the vial is 99% peptide by weight?
Not automatically. Read what the percentage represents. A UV chromatographic peak-area percentage describes the integrated detector response under that analytical method. It should not be silently rewritten as the fraction of every substance in the container. The wavelength, separation and integration matter to interpreting the result.
A report that displays only a number gives the reader less context than one that identifies the sample, method and chromatogram. Ask for the relevant analytical record when that context is necessary. Do not draw or invent an unseen chromatogram to make a short report appear more complete.
For the different question of total powder, peptide content and measured amount, use the COA reading guide. Keep each number beside its unit and stated reporting basis.
Does mass spectrometry prove everything about identity?
Read the laboratory’s actual identity conclusion and its supporting criteria. A heading saying “MS tested” leaves unanswered what was observed, what was expected and how the comparison was evaluated. Mass confirmation is useful information; do not broaden a limited report into a claim of complete structural characterization.
Waters demonstrates the complementary use of LC-UV and MS in a synthetic-peptide application note. Its eledoisin example uses chromatographic and mass information for target confirmation and impurity profiling, with stated thresholds and analysis conditions. Those are method-specific findings, not universal performance guarantees for every peptide report. Waters: synthetic-peptide identification and impurity profiling.
If a listing and a report show different molecular-weight numbers, use why peptide molecular weights differ between records to compare the mass convention, ion label and exact material description before interpreting the discrepancy.
How should I review a report that lists both tests?
Consider a fictional training record: a report names Sample Q, reports a chromatographic purity percentage and states that the observed mass is consistent with its target. No amount per vial or current-stock connection is provided. This is not a report for a Peptide Serum product.
- Record the supported findings: the purity result under its stated definition and the reported mass comparison.
- Keep the blank fields blank: do not calculate a measured fill from an unverified label claim.
- Check the report’s scope: identify which sample and tests the issuer actually describes.
- Verify separately: use the issuer’s verification process and review the relationship between that sample and the relevant lot.
- Request the missing record: describe the unanswered question rather than asking whether the instrument name is “good enough.”
A useful conclusion would retain the limits: “The report contains these two analytical findings for the named sample; an amount-per-vial finding and current-stock connection have not been established in the supplied record.” That conclusion can be revised when additional evidence arrives.
Apply the same reading process to an exact material rather than a broad family name. For example, the Semax research profile and Semax 10 mg listing serve different purposes. A paper about the compound does not verify the catalog item’s lot. Request available Peptide Serum documentation through Lab Testing.
Published October 21, 2026. The cited manufacturers explain analytical methods; no affiliation, product certification or independent verification of this store is implied.